The Diagnostic Value of Triggering Receptor Expressed on Myeloid Cells-1 in Post-Traumatic Bacterial Endophthalmitis

Qiuyang Tang1, Mengxuan He1, Shudan Zhang1

  • 1Department of Ophthalmology, the Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.

Abstract

Insights

Soluble-triggering receptor expressed on myeloid cells-1 (sTREM-1) shows promise as a biomarker for diagnosing post-traumatic bacterial endophthalmitis (PTBE), particularly culture-negative cases. Elevated sTREM-1 levels correlate with inflammation and PTBE severity.

Area of Science:

  • Ophthalmology
  • Immunology
  • Biomarker Discovery

Background:

  • Post-traumatic bacterial endophthalmitis (PTBE) poses a significant risk to vision.
  • Accurate and timely diagnosis is crucial for effective treatment.
  • Current diagnostic methods may have limitations, especially in culture-negative scenarios.

Purpose of the Study:

  • To investigate the diagnostic utility of soluble-triggering receptor expressed on myeloid cells-1 (sTREM-1) as a biomarker for PTBE.
  • To assess the correlation between vitreous sTREM-1 levels and disease severity.

Main Methods:

  • Vitreous fluid samples were analyzed for sTREM-1 levels using ELISA in patients with PTBE, noninfected intraocular conditions, and controls.
  • Immunohistochemistry was used to determine TREM-1 expression in ocular tissues.
  • Receiver operating characteristic (ROC) curve analysis evaluated the diagnostic performance of sTREM-1.
  • Correlation with visual acuity and clinical severity scores was assessed.

Main Results:

  • Vitreous sTREM-1 levels were significantly higher in the PTBE group compared to controls and noninfected groups.
  • sTREM-1 demonstrated moderate diagnostic efficiency (AUC = 0.79) for differentiating PTBE.
  • Sensitivity was 62.50% and specificity was 86.25% for sTREM-1 at a cutoff of >524.50 pg/mL.
  • TREM-1 was highly expressed on neutrophils and monocytes/macrophages in PTBE eyes.
  • sTREM-1 levels positively correlated with the Peyman endophthalmitis score (PES) but not with visual acuity.

Conclusions:

  • sTREM-1 is a promising biomarker for diagnosing PTBE, especially in culture-negative cases.
  • Vitreous sTREM-1 levels reflect intraocular inflammation and disease severity in PTBE.
  • Further research may validate sTREM-1 for clinical application in PTBE diagnosis.